J Caro

Summary

Affiliation: Caro Research Institute
Country: USA

Publications

  1. ncbi Hospitalization for pertussis: profiles and case costs by age
    Judith A O'Brien
    Caro Research Institute, 336 Baker Avenue, Concord, MA, USA
    BMC Infect Dis 5:57. 2005
  2. ncbi Cost of managing complications resulting from type 2 diabetes mellitus in Canada
    Judith A O'Brien
    Caro Research Institute, Concord, MA, USA
    BMC Health Serv Res 3:7. 2003
  3. ncbi Cost of managing an episode of relapse in multiple sclerosis in the United States
    Judith A O'Brien
    Caro Research Institute, Concord, MA 01742, USA
    BMC Health Serv Res 3:17. 2003
  4. ncbi Are proton pump inhibitors the first choice for acute treatment of gastric ulcers? A meta analysis of randomized clinical trials
    Maribel Salas
    Caro Research Institute, 336 Baker Avenue, Concord, MA 01742, USA
    BMC Gastroenterol 2:17. 2002
  5. ncbi An international survey of patients with thalassemia major and their views about sustaining life-long desferrioxamine use
    Alexandra Ward
    Caro Research Institute, Concord, MA, USA
    BMC Clin Pharmacol 2:3. 2002
  6. ncbi The morbidity and mortality following a diagnosis of peripheral arterial disease: long-term follow-up of a large database
    Jaime Caro
    Caro Research Institute, Concord, MA, USA
    BMC Cardiovasc Disord 5:14. 2005
  7. ncbi Modelling the health benefits and economic implications of implanting dual-chamber vs. single-chamber ventricular pacemakers in the UK
    Jaime Caro
    Caro Research Institute, 336 Baker Avenue, Concord, MA 01742, USA
    Europace 8:449-55. 2006
  8. ncbi Cost-benefit analysis of preventing sudden cardiac deaths with an implantable cardioverter defibrillator versus amiodarone
    J Jaime Caro
    Caro Research Institute, Concord, MA 01742, USA
    Value Health 10:13-22. 2007
  9. ncbi To what degree does cognitive impairment in Alzheimer's disease predict dependence of patients on caregivers?
    Jaime Caro
    Division of General Internal Medicine, McGill University, Montreal, Canada
    BMC Neurol 2:6. 2002
  10. ncbi Invasive meningococcal disease epidemiology and control measures: a framework for evaluation
    J Jaime Caro
    Caro Research Institute, Concord, MA, USA
    BMC Public Health 7:130. 2007

Detail Information

Publications82

  1. ncbi Hospitalization for pertussis: profiles and case costs by age
    Judith A O'Brien
    Caro Research Institute, 336 Baker Avenue, Concord, MA, USA
    BMC Infect Dis 5:57. 2005
    ..It has been reported that from 1997-2000, 20% of all pertussis cases required hospitalization in the US. This analysis examined demographics, case fatality rate, resource use and costs of hospital care related to pertussis by age...
  2. ncbi Cost of managing complications resulting from type 2 diabetes mellitus in Canada
    Judith A O'Brien
    Caro Research Institute, Concord, MA, USA
    BMC Health Serv Res 3:7. 2003
    ..Data were obtained from many Canadian sources, including the Ontario Case Cost Project, physician and laboratory fee schedules, formularies, reports, and literature. All costs are expressed in 2000 Canadian dollars...
  3. ncbi Cost of managing an episode of relapse in multiple sclerosis in the United States
    Judith A O'Brien
    Caro Research Institute, Concord, MA 01742, USA
    BMC Health Serv Res 3:17. 2003
    ..The purpose of this study was to determine the direct medical US cost of managing multiple sclerosis relapses...
  4. ncbi Are proton pump inhibitors the first choice for acute treatment of gastric ulcers? A meta analysis of randomized clinical trials
    Maribel Salas
    Caro Research Institute, 336 Baker Avenue, Concord, MA 01742, USA
    BMC Gastroenterol 2:17. 2002
    ..This evidence suggests that the first choice for gastric ulcer treatment for the greater relief of symptoms is one of the newer PPIs...
  5. ncbi An international survey of patients with thalassemia major and their views about sustaining life-long desferrioxamine use
    Alexandra Ward
    Caro Research Institute, Concord, MA, USA
    BMC Clin Pharmacol 2:3. 2002
    ..The objective of this study was to investigate patients' reasons for missing iron chelation therapy with desferrioxamine, and the support to sustain life-long adherence to treatment...
  6. ncbi The morbidity and mortality following a diagnosis of peripheral arterial disease: long-term follow-up of a large database
    Jaime Caro
    Caro Research Institute, Concord, MA, USA
    BMC Cardiovasc Disord 5:14. 2005
    ..Awareness of the significance of peripheral arterial disease is increasing, but quantitative estimates of the ensuing burden and the impact of other risk factors remains limited. The objective of this study was to fill this need...
  7. ncbi Modelling the health benefits and economic implications of implanting dual-chamber vs. single-chamber ventricular pacemakers in the UK
    Jaime Caro
    Caro Research Institute, 336 Baker Avenue, Concord, MA 01742, USA
    Europace 8:449-55. 2006
    ..To estimate the consequences of managing bradycardia due to sinoatrial node disease or atrioventricular block with dual-chamber vs. single-chamber ventricular pacemakers...
  8. ncbi Cost-benefit analysis of preventing sudden cardiac deaths with an implantable cardioverter defibrillator versus amiodarone
    J Jaime Caro
    Caro Research Institute, Concord, MA 01742, USA
    Value Health 10:13-22. 2007
    ..To conduct a cost-benefit assessment of prevention of sudden cardiac deaths with an implantable cardioverter defibrillator (ICD) versus amiodarone from the perspective of the health-care systems in the UK and France...
  9. ncbi To what degree does cognitive impairment in Alzheimer's disease predict dependence of patients on caregivers?
    Jaime Caro
    Division of General Internal Medicine, McGill University, Montreal, Canada
    BMC Neurol 2:6. 2002
    ..In this study, we investigated the relationship of cognitive function to dependence on caregivers before the patients reach a severe stage of the disease...
  10. ncbi Invasive meningococcal disease epidemiology and control measures: a framework for evaluation
    J Jaime Caro
    Caro Research Institute, Concord, MA, USA
    BMC Public Health 7:130. 2007
    ..In the absence of long-term real world data, modeling the effects of different vaccination strategies is required. Discrete event simulation provides a flexible platform with which to conduct such evaluations...
  11. ncbi The risk of diabetes during olanzapine use compared with risperidone use: a retrospective database analysis
    J Jaime Caro
    Caro Research Institute, Concord, Mass, USA
    J Clin Psychiatry 63:1135-9. 2002
    ..The relative risk of diabetes among patients undergoing risperidone treatment was compared with that of patients receiving olanzapine...
  12. ncbi Economic burden of pertussis and the impact of immunization
    J Jaime Caro
    Caro Research Institute, Concord, MA 01742, USA
    Pediatr Infect Dis J 24:S48-54. 2005
    ..Despite the existing gaps in data, further research using the most current data should facilitate decisions on new vaccination strategies by describing conditions for favorable results and quantifying the margin of uncertainty...
  13. ncbi Economic evaluation of therapeutic interventions to prevent Type 2 diabetes in Canada
    J J Caro
    Caro Research Institute, 336 Baker Avenue, Concord, MA 01742, USA
    Diabet Med 21:1229-36. 2004
    ..To compare the health and economic outcomes of using acarbose, an intensive lifestyle modification programme, metformin or no intervention to prevent progression to diabetes in Canadian individuals with impaired glucose tolerance (IGT)...
  14. ncbi Estimating survival for cost-effectiveness analyses: a case study in atherothrombosis
    J Jaime Caro
    Caro Research Institute, Concord, MA 01742, USA
    Value Health 7:627-35. 2004
    ..Economic evaluations typically require estimates of survival beyond the limited follow-up in clinical trials. The objective of this study was to demonstrate a data-driven approach to deriving these estimates...
  15. ncbi Comparing medications in a therapeutic area using an NNT model
    J Jaime Caro
    Caro Research Institute, Concord, MA 01742, USA
    Value Health 7:585-94. 2004
    ....
  16. ncbi The impact of compliance with osteoporosis therapy on fracture rates in actual practice
    J Jaime Caro
    Caro Research Institute, 336 Baker Avenue, Concord, MA 01742, USA
    Osteoporos Int 15:1003-8. 2004
    ..Noncompliance could considerably limit the effectiveness observed in actual practice, however. The objective of this study was therefore to estimate fracture risk in relation to compliance with osteoporosis medication in actual practice...
  17. ncbi Pertussis immunization of adolescents in the United States: an economic evaluation
    J Jaime Caro
    Caro Research Institute, Concord, MA 01742, USA
    Pediatr Infect Dis J 24:S75-82. 2005
    ..Although there is considerable uncertainty surrounding key inputs, the results indicate that the conditions required for adolescent immunization to be economically warranted are realistic...
  18. ncbi Modeling the efficiency of reaching a target intermediate end point: a case study in type 2 diabetes in the United States
    J Jaime Caro
    Caro Research Institute, Concord, MA, USA
    Value Health 7:13-21. 2004
    ..A case study addresses the economic efficiency of obtaining dual glycemic control over time, according to initial choice of treatment...
  19. ncbi Allocating funds for cardiovascular disease prevention in light of the NCEP ATP III guidelines
    Jaime Caro
    Caro Research Institute, 336 Baker Avenue, Concord, MA 01742, USA
    Am J Manag Care 9:477-89. 2003
    ..Controversy persists about the most efficient allocation of healthcare funds for cardiovascular disease prevention. Previous economic analyses have generally focused on primary or secondary prevention as discrete categories...
  20. ncbi Pharmacoeconomic analyses using discrete event simulation
    J Jaime Caro
    Caro Research Institute, 336 Baker Avenue, Concord, MA 01742, USA
    Pharmacoeconomics 23:323-32. 2005
    ....
  21. ncbi Economic analysis of galantamine, a cholinesterase inhibitor, in the treatment of patients with mild to moderate Alzheimer's disease in the Netherlands
    J Jaime Caro
    Caro Research Institute, Boston, Mass, USA
    Dement Geriatr Cogn Disord 14:84-9. 2002
    ..The economic impact of dementia on the Dutch health and social services is substantial...
  22. ncbi Economic analysis of initial HIV treatment. Efavirenz- versus indinavir-containing triple therapy
    J J Caro
    Caro Research, Concord, Massachusetts, USA
    Pharmacoeconomics 19:95-104. 2001
    ..To compare the clinical and economic outcomes associated with triple therapy containing efavirenz or indinavir and 2 nucleoside reverse transcriptase inhibitors (NRTIs; zidovudine and lamivudine) in HIV-positive patients...
  23. ncbi Stroke treatment economic model (STEM): predicting long-term costs from functional status
    J J Caro
    Caro Research, Concord, MA 01742, USA
    Stroke 30:2574-9. 1999
    ..As new therapies for acute ischemic stroke are forthcoming, there is an increasing need to understand their long-term economic implications. To address this need, a stroke economic model was created...
  24. ncbi Management patterns and costs of acute ischemic stroke : an international study. For the Stroke Economic Analysis Group
    J J Caro
    Caro Research, Concord, MA 1742, USA
    Stroke 31:582-90. 2000
    ..corrected] With the ever-increasing pressure on healthcare budgets, we witness a growing demand for evidence of the economic implications of care across many therapeutic areas. Stroke is no exception...
  25. ncbi Are the WOSCOPS clinical and economic findings generalizable to other populations? A case study for Belgium. The WOSCOPS Economic Analysis Group. West of Scotland Coronary Prevention Study
    J J Caro
    Caro Research, Concord, MA, USA
    Acta Cardiol 55:239-46. 2000
    ..This study examines the legitimacy of this concern, using Belgium as a case study...
  26. ncbi Predicting treatment costs after acute ischemic stroke on the basis of patient characteristics at presentation and early dysfunction
    J J Caro
    Caro Research, Concord, MA 01742, USA
    Stroke 32:100-6. 2001
    ..Understanding the predictors of cost provides an efficient means of incorporating such information in decision-making concerning new therapies...
  27. ncbi Could chest X-ray screening for lung cancer be cost-effective?
    J J Caro
    Caro Research, Concord, Massachusetts, USA
    Cancer 89:2502-5. 2000
    ..If a screening program is to be considered, its potential economic impact needs to be assessed...
  28. ncbi Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data
    J J Caro
    Caro Research, Concord, Mass, USA
    CMAJ 160:41-6. 1999
    ..This paper examines the effect of initial choice of treatment on persistence with therapy in actual practice...
  29. ncbi Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review
    J J Caro
    Division of General Internal Medicine, McGill University, Montreal, Quebec, Canada
    Cancer 91:2214-21. 2001
    ..The objective of this study was to systematically review, to summarize, and to obtain an overall estimate of the effect of anemia on survival in patients with malignant disease...
  30. ncbi Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials
    J J Caro
    Division of General Internal Medicine, McGill University, Montreal, Quebec, Canada
    Clin Ther 23:998-1017. 2001
    ..The older proton pump inhibitor (PPI) omeprazole and the newer PPIs lansoprazole, rabeprazole, and pantoprazole are approved for the acute and maintenance treatment of gastroesophageal reflux disease (GERD)...
  31. ncbi Assessment of health economics in Alzheimer's disease (AHEAD) based on need for full-time care
    J J Caro
    Caro Research Institute, Concord, MA 01742, USA
    Neurology 57:964-71. 2001
    ..To develop a framework for estimating the long-term health and economic consequences of AD based on patient characteristics at a given point in time...
  32. ncbi Pharmacoeconomic evidence and considerations for triptan treatment of migraine
    J Jaime Caro
    Caro Research Institute, 336 Baker Avenue, Concord, MA, USA
    Expert Opin Pharmacother 3:237-48. 2002
    ..Thus far, few analyses have explicitly included quality of life (QOL) in their analyses and pharmacoeconomic analyses comparing the different triptans are scant. More research is required in these areas...
  33. ncbi Does electronic implementation of questionnaires used in asthma alter responses compared to paper implementation?
    J J Caro
    Division of Respiratory Medicine, Santa Cabrini Hospital, Montreal, Canada
    Qual Life Res 10:683-91. 2001
    ..Electronic implementation of questionnaires has many advantages, but there may be concerns that it alters versions that were validated on paper...
  34. ncbi Persistence with treatment for hypertension in actual practice
    J J Caro
    Caro Research, Concord, Mass, USA
    CMAJ 160:31-7. 1999
    ..Randomized clinical trials, cannot address this issue well given their highly restricted environment. This paper examines persistence with antihypertensive therapy among patients in actual practice...
  35. ncbi The West of Scotland coronary prevention study: economic benefit analysis of primary prevention with pravastatin
    J Caro
    Caro Research, Concord, MA 01742, USA
    BMJ 315:1577-82. 1997
    ..To estimate the economic efficiency of using pravastatin to prevent the transition from health to cardiovascular disease in men with hypercholesterolaemia...
  36. ncbi Lifetime costs of complications resulting from type 2 diabetes in the U.S
    J Jaime Caro
    Caro Research Institute, Concord, Massachusetts, USA
    Diabetes Care 25:476-81. 2002
    ..To model the lifetime costs associated with complications of type 2 diabetes...
  37. ncbi The time course of subsequent hospitalizations and associated costs in survivors of an ischemic stroke in Canada
    J Jaime Caro
    Caro Research Institute, Concord, MA, USA
    BMC Health Serv Res 6:99. 2006
    ..Documentation of the hospitalizations rates following a stroke provides the inputs required for planning health services and to evaluate the economic efficiency of any new therapies...
  38. ncbi Cost effectiveness of tinzaparin sodium versus unfractionated heparin in the treatment of proximal deep vein thrombosis
    J Jaime Caro
    Caro Research Institute, Concord, Massachusetts 01742, USA
    Pharmacoeconomics 20:593-602. 2002
    ....
  39. ncbi Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice
    J J Caro
    Caro Research, Concord, Mass, USA
    CMAJ 161:493-7. 1999
    ..The authors conducted a prospective observational study to evaluate the effect of preventive anticoagulation in patients with atrial fibrillation in 2 practice settings in Montreal...
  40. ncbi Economic evaluation of galantamine in the treatment of mild to moderate Alzheimer's disease in the United States
    Kristen Migliaccio-Walle
    Caro Research Institute, Concord, Massachusetts 01742, USA
    Clin Ther 25:1806-25. 2003
    ..CONCLUSIONS: These results suggest that use of galantamine in patients with AD in the United States could reduce the use of costly resources such as formal home care and nursing homes, leading to cost savings over time...
  41. ncbi Budgetary impact of treating acute bipolar mania in hospitalized patients with quetiapine: an economic analysis of clinical trials
    J Jaime Caro
    Caro Research Institute, Concord, MA 01742, USA
    Curr Med Res Opin 22:2233-42. 2006
    ..In addition, this model illustrates that discrete event simulation is a useful and versatile tool for budget impact analyses...
  42. ncbi Economic outcomes associated with microvascular complications of type 2 diabetes mellitus: results from a US claims data analysis
    Elise M Pelletier
    Health Economics and Outcomes Research, IMS Health Incorporated, Watertown, Massachusetts, USA
    Pharmacoeconomics 27:479-90. 2009
    ..Recent studies have focused on MVC and their effect on the healthcare system, but limited published data exist on long-term costs associated with MVC in patients with type 2 diabetes mellitus (T2DM)...
  43. ncbi Prevention and management of hyperphosphatemia with sevelamer in Canada: health and economic consequences
    Krista F Huybrechts
    Caro Research Institute, Concord, MA 01742, USA
    Value Health 12:16-9. 2009
    ..This intervention was shown to be cost-effective in the United States. This paper presents the Canadian adaptation...
  44. ncbi Instituting a routine varicella vaccination program in Canada: an economic evaluation
    Denis Getsios
    Caro Research, Montreal, Canada
    Pediatr Infect Dis J 21:542-7. 2002
    ..These findings are consistent with evaluations in other countries...
  45. ncbi Costs and medical care consequences associated with the diagnosis of peripheral arterial disease
    Kristen Migliaccio-Walle
    Caro Research Institute, Boston, Massachusetts 01742, USA
    Pharmacoeconomics 23:733-42. 2005
    ..By the end of year 1, this burden is comparable with a diagnosis of MI...
  46. ncbi Impact of thalassemia major on patients and their families
    J Jaime Caro
    Caro Research Institute, Concord, MA 07142, USA
    Acta Haematol 107:150-7. 2002
    ..To describe the burden of thalassemia major and its treatment, in terms of prevalence of iron-overload-related complications, direct and indirect costs, and the patient's physical and social well-being...
  47. ncbi Meta-analysis of longitudinal studies
    K Jack Ishak
    Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada
    Clin Trials 4:525-39. 2007
    ..Meta-analyses of these studies must account for correlations between effect estimates from the same study...
  48. ncbi Modelling the economic and health consequences of cardiac resynchronization therapy in the UK
    J Jaime Caro
    Caro Research Institute, Concord, MA, USA
    Curr Med Res Opin 22:1171-9. 2006
    ..Sensitivity analyses revealed that this outcome was most sensitive to time horizon and cost of implantation. CONCLUSION: Based on these 5-year analyses, CRT is expected to yield substantial health benefits at a reasonable cost...
  49. ncbi Managing meningococcal disease in the United States: Hospital case characteristics and costs by age
    Judith A O'Brien
    Caro Research Institute, Concord, MA 01742, USA
    Value Health 9:236-43. 2006
    ..The goal of this analysis was to examine hospitalized cases of meningitis and meningococcemia to identify case characteristics, resource use, and inpatient care costs...
  50. ncbi The emerging infectious challenge of clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences
    Judith A O'Brien
    Caro Research Institute, Concord, MA, 01742, USA
    Infect Control Hosp Epidemiol 28:1219-27. 2007
    ..To estimate the clinical and economic burden of Clostridium difficile-associated disease (CDAD) in Massachusetts over 2 years...
  51. ncbi Clinical and economic burden of infused iron chelation therapy in the United States
    Krista A Payne
    Caro Research Institute, 185 Dorval Avenue, Montreal, Quebec, Canada
    Transfusion 47:1820-9. 2007
    ..Current ICT requires burdensome 8- to 12-hour infusions five to seven times per week...
  52. ncbi Economic implications of growth hormone use in patients with short bowel syndrome
    Kristen Migliaccio-Walle
    Caro Research Institute, Concord, MA 01742, USA
    Curr Med Res Opin 22:2055-63. 2006
    ..05). This study evaluates the economic impact of somatropin use in the management of short bowel syndrome...
  53. ncbi Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphone
    Alexandra Ward
    Caro Research Institute, Concord, MA 01742, USA
    Curr Med Res Opin 23:2333-45. 2007
    ..This simulation compared managing chronic osteoarthritis pain with once-daily OROS hydromorphone with an equianalgesic dose of extended-release (ER) oxycodone administered two or three times a day...
  54. ncbi Long term cost-of-illness in stroke: an international review
    Krista A Payne
    Caro Research Institute, Montreal, Quebec, Canada
    Pharmacoeconomics 20:813-25. 2002
    ..Consensus on standard cost variables and methods for projections of resource use and survival over time are clearly warranted...
  55. ncbi The Barthel Index and modified Rankin Scale as prognostic tools for long-term outcomes after stroke: a qualitative review of the literature
    Krista F Huybrechts
    Caro Research Institute, 336 Baker Avenue, Concord, MA 01742, USA
    Curr Med Res Opin 23:1627-36. 2007
    ..Thus, we critically reviewed the evidence supporting the prognostic value of two frequently-used measures, the Barthel Index (BI) and modified Rankin Scale (mRS) for long-term outcomes...
  56. ncbi Economic and health consequences of managing bradycardia with dual-chamber compared to single-chamber ventricular pacemakers in Italy
    Huseyin Baris Deniz
    Caro Research Institute, Concord, Massachusetts 01742, USA
    J Cardiovasc Med (Hagerstown) 9:43-50. 2008
    ..Dual-chamber pacemakers lower the risk of developing atrial fibrillation and pacemaker syndrome...
  57. ncbi Assessment of compliance with osteoporosis treatment and its consequences in a managed care population
    Krista F Huybrechts
    Caro Research Institute, 336 Baker Avenue, Concord, MA 01742, USA
    Bone 38:922-8. 2006
    ..To evaluate non-compliance with osteoporosis medications as well as its implications for health and economic outcomes in actual practice...
  58. ncbi Modeling the implications of changes in vascular calcification in patients on hemodialysis
    Krista F Huybrechts
    Caro Research Institute, 336 Baker Avenue, Concord, MA 01742, USA
    Kidney Int 67:1532-8. 2005
    ..To understand the implications of this effect for cardiovascular events, risk equations are needed...
  59. ncbi Describing cognitive decline of patients at the mild or moderate stages of Alzheimer's disease using the Standardized MMSE
    Alexandra Ward
    Caro Research Institute, Concord, Massachusetts 01742, USA
    Int Psychogeriatr 14:249-58. 2002
    ..To describe the progression of patients with mild or moderate Alzheimer's disease (AD) to a severe stage using the Standardized Mini-Mental State Examination (SMMSE)...
  60. ncbi Assessment of Health Economics in Alzheimer's Disease (AHEAD): treatment with galantamine in Sweden
    Frances B Garfield
    Caro Research Institute, Concord, Massachusetts 01742, USA
    Pharmacoeconomics 20:629-37. 2002
    ..Galantamine, a new acetylcholinesterase inhibitor and nicotinic modulator, has proved effective in managing patients with Alzheimer's disease in clinical trials...
  61. ncbi Health and economic consequences of sevelamer use for hyperphosphatemia in patients on hemodialysis
    Krista F Huybrechts
    Caro Research Institute, Concord, MA 01742, USA
    Value Health 8:549-61. 2005
    ..Thus, a model of the predicted long-term consequences of sevelamer compared with calcium-based binders (acetate and carbonate) was developed...
  62. ncbi Risk of discontinuation of risperidone after exposure to potentially interacting drugs: a nested case-control study in patients with schizophrenia
    K Jack Ishak
    United BioSource Corporation, Montreal, Quebec, Canada
    Clin Ther 30:1251-63. 2008
    ....
  63. ncbi Canadian economic comparison of extended-release oxybutynin and immediate-release tolterodine in the treatment of overactive bladder
    Denis Getsios
    Caro Research Institute, Hammonds Plains, Nova Scotia, Canada
    Clin Ther 26:431-8. 2004
    ..CONCLUSION: The results of these analyses suggest that when priced equivalently, oxybutynin XL would reduce costs and provide better results than tolterodine IR over 1 year of treatment...
  64. ncbi Case-control studies in pharmacoeconomic research: an overview
    J Jaime Caro
    Department of Epidemiology, Biostatistics and Occupational Health, and Division of General Internal Medicine, McGill University, Montreal, Canada
    Pharmacoeconomics 27:627-34. 2009
    ....
  65. ncbi Pharmacological management of overactive bladder : a systematic and critical review of published economic evaluations
    Denis Getsios
    Caro Research Institute, Halifax, Nova Scotia, Canada
    Pharmacoeconomics 23:995-1006. 2005
    ..A more definitive pharmacoeconomic comparison of oxybutynin and tolterodine formulations, incorporating all available clinical data, and other treatment options would help direct treatment...
  66. ncbi QALYs: are they helpful to decision makers?
    Maurice McGregor
    Technology Assessment Unit, McGill University Health Centre, Montreal, Quebec, Canada
    Pharmacoeconomics 24:947-52. 2006
    ....
  67. ncbi No head-to-head trial? simulate the missing arms
    J Jaime Caro
    Division of General Internal Medicine and Department of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University, Montreal, Quebec, Canada
    Pharmacoeconomics 28:957-67. 2010
    ..An STC offers a way to derive comparative effectiveness in the absence of direct trial evidence and a platform to test design features that may help in planning future head-to-head studies...
  68. ncbi An economic model of stroke in atrial fibrillation: the cost of suboptimal oral anticoagulation
    J Jaime Caro
    Caro Research, Concord, Massachusetts, USA
    Am J Manag Care 10:S451-58; discussion S458-61. 2004
    ....
  69. ncbi Quality of clinical documentation and anticoagulation control in patients with chronic nonvalvular atrial fibrillation in routine medical care
    Jack Ansell
    Department of Medicine, Boston University, Boston, MA 02118, USA
    Am J Med Qual 22:327-33. 2007
    ..Anticoagulation quality and record documentation were retrospectively assessed in patients with chronic nonvalvular atrial fibrillation (CNVAF) managed in a routine care setting...
  70. ncbi Regarding probabilistic analysis and computationally expensive models: necessary and required?
    J Jaime Caro
    Value Health 10:317-8; author reply 319. 2007
  71. ncbi An economic evaluation of atenolol vs. captopril in patients with type 2 diabetes (UKPDS 24)
    J Jaime Caro
    Curr Hypertens Rep 4:417. 2002
  72. ncbi Summary: health and economic burden of pertussis
    David P Greenberg
    University of Pittsburgh School of Medicine, Division of Allergy, Immunology and Infectious Diseases, Children's Hospital of Pittsburgh, Pittsburgh, PA, USA
    Pediatr Infect Dis J 24:S55-7. 2005
  73. ncbi Potential strategies to reduce the burden of pertussis
    Kevin Forsyth
    Flinders University, Adelaide, Australia
    Pediatr Infect Dis J 24:S69-74. 2005
    ..However, certain steps can be taken now to reduce the incidence of pertussis...
  74. ncbi Cost-effectiveness of cardiac resynchronization therapy
    Alexandra Ward
    J Am Coll Cardiol 48:1283. 2006
  75. ncbi Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension
    J Jaime Caro
    Curr Hypertens Rep 4:417-8. 2002
  76. ncbi Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic
    J Jaime Caro
    Curr Hypertens Rep 4:418. 2002
  77. ncbi An interview with J. Jaime Caro
    J Jaime Caro
    Am J Manag Care 10:S307-11. 2004
    ..Caro recently reported preliminary results from his economic analyses at the 2004 World Stroke Congress in Vancouver, BC. He spoke with an editor from AJMC about those studies...
  78. ncbi Pharmacoutilization of antihypertensive drugs: a model of analysis
    J Jaime Caro
    Curr Hypertens Rep 4:419. 2002
  79. ncbi Recommendations for evaluating compliance and persistence with hypertension therapy using retrospective data
    Michael T Halpern
    Hypertension 47:1039-48. 2006
  80. ncbi The effect of eflornithine 13.9% cream on the bother and discomfort due to hirsutism
    Joseph Jackson
    Bristol Myers Squibb Pharmaceutical Research Institute, Princeton, New Jersey, USA
    Int J Dermatol 46:976-81. 2007
    ..46 to 1.62. Eflornithine is an effective treatment for unwanted facial hair in women, as reported by the patients. ESTEEM addresses the specific concerns of women with hirsutism...
  81. ncbi Ignoring study design heterogeneity in meta-analyses
    J Jaime Caro
    Arch Intern Med 166:2046; author reply 2046-7. 2006
  82. ncbi Optimizing oral anticoagulation in managed care
    J Jaime Caro
    Caro Research, Concord, Massachusetts, USA
    Am J Manag Care 10:S474-7. 2004